BiotechTube
Home/FerroptoCure/Nobuhiro Nishiyama
NN

Nobuhiro Nishiyama

Director, Ph.D.

FerroptoCure

Therapeutic Areas

Oncology

FerroptoCure Pipeline

DrugIndicationPhase
FC001Cancer (unspecified)Phase 1
FC004Cancer (unspecified)Preclinical

Leadership Team at FerroptoCure

YO
Yuji Otsuki
CEO, M.D., Ph.D.
HS
Hideyuki Saya
Director, M.D., Ph.D.
ON
Osamu Nagano
Director, DDS., Ph.D.
TN
Toru Natsume
Director, Ph.D. (CSO at RBI)
View full FerroptoCure profile